A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Assistance Publique - Hôpitaux de Paris
Washington University School of Medicine
Ossium Health, Inc.
New York Medical College
xCures
Sanguine Biosciences
Hospital Universitari Vall d'Hebron Research Institute